GlassScriptPhysician profile
Levi J Keller
NPI 1568967024
$10,923.43
in general payments reported to CMS, 2019-2025
11 companies · $9,164 in 2025
The $9,164 reported for 2025 was more than what 88% of Allergy & Immunology providers received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $558 · 2022: $637 · 2023: $299 · 2024: $266 · 2025: $9,164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,712 · Food and Beverage: $1,343 · Travel and Lodging: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,712.00 |
| Food and Beverage | $1,342.74 |
| Travel and Lodging | $673.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $9,578.04 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $746.37 | 2021-2025 | Fasenra |
| Genentech, INC. | $145.98 | 2025 | Xolair |
| Regeneron Healthcare Solutions, INC. | $121.13 | 2021 | |
| Pharming Healthcare, INC. | $105.46 | 2023 | Ruconest |
| Glaxosmithkline, LLC. | $105.25 | 2021 | |
| Novartis Pharmaceuticals Corporation | $32.93 | 2023-2025 | |
| Genentech USA, INC. | $28.33 | 2022 | |
| Csl Behring | $25.22 | 2025 | Andembry |
| Biocryst US Sales Co., LLC | $21.03 | 2021 | |
| Cycle Pharmaceuticals INC | $13.69 | 2025 | Sajazir |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Levi Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.